Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND1 pseudogene 7 (MTND1P7) is a mitochondrial pseudogene related to the functional MT-ND1 gene, which encodes a subunit of mitochondrial complex I (NADH: ubiquinone oxidoreductase). MTND1P7 does not encode a functional protein, has no established biological function, and is not considered a therapeutic or diagnostic target. Its presence is likely the result of gene duplication or retrotransposition and serves primarily as a marker for genomic structure or evolutionary study but not for clinical or pharmacological intervention. Key point: MTND1P7 is a nonfunctional pseudogene and should not be considered a therapeutic target, receptor, or active participant in biological pathways. For drug targeting or disease relevance, refer instead to the functional MT-ND1 gene[1][2][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1 pseudogene 7 (MTND1P7).